UTC Therapeutics Inc.
3 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| UCL70805F in Patients With CD70-positive Advanced Renal Clear Cell Carcinoma (NCT07500805) | UTC Therapeutics Inc. | 2026-05-01 |
| Anti-HER2 CAR-T Cell Injection in Patients With HER2-positive Advanced Malignant Solid Tumors (NCT06658951) | UTC Therapeutics Inc. | 2025-04-03 |
| Phase 1 Study of UCMYM802 Injection in Mesothelin-positive Advanced Malignant Solid Tumors (NCT06256055) | UTC Therapeutics Inc. | 2024-03-05 |
Track UTC Therapeutics Inc. automatically
Every clearance here is in the API, with alerts when new ones post.